BACKGROUND: By using a microbubble contrast agent and contrast-specific imaging software, the contrast-enhanced ultrasound (CEUS) is able to depict the micro and macrocirculation of the target organ. METHODS: A review of the peer reviewed literature was done regarding the current role of ultrasound CEUS imaging in the evaluation of renal pathology with reference to the diagnosis of renal ischaemia, in the characterization of complex cystic lesions and in those with equivocal enhancement at CT. RESULTS: CEUS provides information on tissue perfusion and may play a role in kidney mass characterization similar to the role of contrast-enhanced CT and MRI. In this context, the characterization of cystic lesions is probably the most consolidated field of application of contrast agents on kidney ultrasound imaging. Finally, CEUS provides a good alternative to CT, especially in patients with contraindications to iodinated contrast agents. CONCLUSIONS: The usefulness of CEUS in these applications is confirmed by extensive literature production and this article focuses on the potential clinical applications of recent advances in CEUS technology in urology.
BACKGROUND: By using a microbubble contrast agent and contrast-specific imaging software, the contrast-enhanced ultrasound (CEUS) is able to depict the micro and macrocirculation of the target organ. METHODS: A review of the peer reviewed literature was done regarding the current role of ultrasound CEUS imaging in the evaluation of renal pathology with reference to the diagnosis of renal ischaemia, in the characterization of complex cystic lesions and in those with equivocal enhancement at CT. RESULTS: CEUS provides information on tissue perfusion and may play a role in kidney mass characterization similar to the role of contrast-enhanced CT and MRI. In this context, the characterization of cystic lesions is probably the most consolidated field of application of contrast agents on kidney ultrasound imaging. Finally, CEUS provides a good alternative to CT, especially in patients with contraindications to iodinated contrast agents. CONCLUSIONS: The usefulness of CEUS in these applications is confirmed by extensive literature production and this article focuses on the potential clinical applications of recent advances in CEUS technology in urology.
Authors: M Claudon; D Cosgrove; T Albrecht; L Bolondi; M Bosio; F Calliada; J-M Correas; K Darge; C Dietrich; M D'Onofrio; D H Evans; C Filice; L Greiner; K Jäger; N de Jong; E Leen; R Lencioni; D Lindsell; A Martegani; S Meairs; C Nolsøe; F Piscaglia; P Ricci; G Seidel; B Skjoldbye; L Solbiati; L Thorelius; F Tranquart; H P Weskott; T Whittingham Journal: Ultraschall Med Date: 2008-02 Impact factor: 6.548
Authors: Angelika Alonso; Alberto Della Martina; Mark Stroick; Marc Fatar; Martin Griebe; Sibylle Pochon; Michel Schneider; Michael Hennerici; Eric Allémann; Stephen Meairs Journal: Stroke Date: 2007-03-22 Impact factor: 7.914
Authors: D-A Clevert; N Minaifar; S Weckbach; E M Jung; K Stock; M Reiser; M Staehler Journal: Clin Hemorheol Microcirc Date: 2008 Impact factor: 2.375
Authors: Johann Le Floc'h; Aimen Zlitni; Holly A Bilton; Melissa Yin; Arash Farhadi; Nancy R Janzen; Mikhail G Shapiro; John F Valliant; F Stuart Foster Journal: Mol Imaging Biol Date: 2018-04 Impact factor: 3.488
Authors: Wolfgang M Thaiss; Jens Bedke; Stephan Kruck; Daniel Spira; Arnulf Stenzl; Konstantin Nikolaou; Marius Horger; Sascha Kaufmann Journal: World J Urol Date: 2018-10-15 Impact factor: 4.226